UNSPSC 51263102: Arotinolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C15H21N3O2S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 394E3P3B99, chemically known as 5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-2-thiophenecarboxamide but generally known as arotinolol, which bears US NIH Compound Identifier 2239. Arotinolol most often comes in base and hydrochloride forms.

UNSPSC 51263102 Arotinolol, a Commodity code, does not map to the state and local solicitations currently tagged under it. The recent opportunities—a Seminole County, Florida naloxone and drug deactivation systems procurement and a Texas Health and Human Services Commission RFI on direct-to-manufacturer prescription fulfillment—fall outside the scope of arotinolol, a specific beta-blocker pharmaceutical used primarily in hypertension and angina management. The code shows little relevant recent activity tied to its nominal pharmaceutical product scope.

The mismatch between code and solicitation suggests miscategorization in the source records rather than active demand for arotinolol procurement at the state and local level. Neither the Seminole County IFB nor the Texas HHS RFI references arotinolol or cardiac pharmaceutical products. A business development professional evaluating this code should flag the taxonomy alignment issue with the procurement source and seek clarification on whether state and local jurisdictions are actively sourcing arotinolol as a formulary item or bulk pharmaceutical good.